MICHAEL PRINCE FOR FORBES
Adam Sachs, cofounder and CEO, of Vicarious Surgical eagerly awaited this morning’s first trade of his surgical robot company under the ticker RBOT on the New York Stock Exchange. “It’s honestly a dream come true,” Sachs, 30, toldSachs, an MIT grad and alum of the 2019 Forbes 30 Under 30 list, officially launched Vicarious in 2014 with his college buddy, Sammy Khalifa, now the company’s chief technology officer, and Dr. Barry Greene.
The surgical robotics market has been dominated by Intuitive Surgical, which introduced its Da Vinci robots two decades ago, and now sports a market cap of $123 billion. As Intuitive’s patents expire and robotic technology advances, competitors including J&J and Medtronic, both of which have acquired surgical-robot startups, are vying to make robotic surgery as common as laparoscopy.
Earlier this year, Vicarious agreed to merge with a SPAC set up by Hong Kong investor Donald Tang in a $1.1 billion deal. With the deal, it will have around $220 million that it intends to use for final stages of product development and FDA clearance. The company has told investors that it hopes its robots will be on the market in 2023, and that it expects to reach $1 billion in annual revenue by 2027.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Source: Slate - 🏆 716. / 51 Read more »
Source: trtworld - 🏆 101. / 63 Read more »
NPR Cookie Consent and ChoicesDeggans People still watch award shows? Deggans Award shows are self-congratulatory masturbation. We don’t need them
Source: NPR - 🏆 96. / 63 Read more »
Source: FashionCanada - 🏆 35. / 63 Read more »
Source: WSJ - 🏆 98. / 63 Read more »
Source: CNBC - 🏆 12. / 72 Read more »